DCAT Global Summit
Stay tuned! Exciting details about the DCAT Global Summit 2026 are coming soon. The next chapter of the DCAT Global Summit begins soon—check back for 2026 event details.
“PCI has been very pleased with DCAT’s strategic approach in broadening to the European based Summit event. The program, the topics and the global supply chain perspective fosters a great environment for rich dialogue, evaluating trends and market innovations, as well as evaluating evolving patient needs both in established and emerging markets. It is a very collaborative and effective event that we are excited to help foster and grow for the benefit of patient focused outcomes. We highly endorse it!”
“The DCAT Summit was one of the most impactful conferences I have attended. The combination of education, networking, and the open sharing of opinions, left me feeling incredibly upbeat about the future of the pharmaceutical industry.”
“The DCAT Summit in Lugano was unlike any other—an inspiring convergence of visionary speakers, fresh perspectives, and meaningful dialogue. The breadth of presentations opened my mind to new possibilities, and the opportunity to connect with senior leaders left me energized and motivated to shape the future of our industry.”
2025 DCAT Summit at Lugano: Key Takeaways and Insights
In a five-article series, DCAT Value Chain Insights provides highlights and perspectives from the DCAT Summit at Lugano: Expedition Pharma – Innovation from a Patient-First Perspective, held June 4–5, 2025, in Lugano, Switzerland.
The first article, Driving Value through Patient-Centricity in Drug Development and the Supply Chain, explores how expert speakers emphasized the ethical and economic imperative of putting patients first—and examined how the industry can more fully realize this all-important goal. Read more in the recap article.
The second article, Innovation at the Foundation of Pharmaceutical Development & Manufacturing, highlights how industry leaders are redefining speed, scalability, and sustainability at the very core of bio/pharmaceutical production. Read more in the recap article.
The third article, Serving Patients through Agility and Innovation in Development and Manufacturing, highlights how leaders from Eli Lilly & Company, Axplora, Made Scientific, and enGene emphasized the essential role of agility and innovation in accelerating complex therapies and designing treatments for real-world patient care. Read more in the recap article.
The fourth article, Innovating Formulation Development & Drug Delivery for Improving Patient Outcomes, highlights how industry leaders at the DCAT Summit in Lugano explored cutting-edge technologies—from nanoparticle engineering to needle-free delivery systems—that are reshaping patient-centric drug design and enhancing treatment outcomes. Read more in the recap article.
Stay tuned as DCAT Value Chain Insights releases a new article each week in this series, offering more expert perspectives and takeaways from the DCAT Summit at Lugano.
2025 Program Overview
This unique conference and networking event underscores the belief that true innovation starts with understanding and prioritizing patient needs. Expedition Pharma: Innovation from a Patient-First Perspective aims to inspire meaningful advancements that leverage cutting-edge technology and forward-thinking strategies to enhance patient care and outcomes with patient-centric solutions.
Explore the industry’s most significant challenges today—from global drug shortages and supply chain disruptions to drug pricing and access, sustainability imperatives, the influence of AI, shifting investment paradigms, and advancing technologies—all from the lens of patient impact and outcomes.
Focusing on innovation, inspiration, and transformation, this conference and networking event is an essential opportunity for C-suite executives, industry thought leaders and decision-makers to connect, collaborate, and exchange groundbreaking strategies that align business goals with patient-centric values.
Thank you to our 2025 sponsors
